Capricor Therapeutics (CAPR) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for Capricor Therapeutics (CAPR) over the last 15 years, with Q3 2025 value amounting to $14.4 million.
- Capricor Therapeutics' Total Non-Current Liabilities rose 24248.84% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year increase of 24248.84%. This contributed to the annual value of $4.0 million for FY2024, which is 1789.97% down from last year.
- Per Capricor Therapeutics' latest filing, its Total Non-Current Liabilities stood at $14.4 million for Q3 2025, which was up 24248.84% from $194603.0 recorded in Q2 2025.
- Capricor Therapeutics' 5-year Total Non-Current Liabilities high stood at $26.0 million for Q1 2022, and its period low was $194603.0 during Q2 2025.
- In the last 5 years, Capricor Therapeutics' Total Non-Current Liabilities had a median value of $4.9 million in 2023 and averaged $8.3 million.
- Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 66078.62% in 2022, then crashed by 9559.76% in 2025.
- Capricor Therapeutics' Total Non-Current Liabilities (Quarter) stood at $5.8 million in 2021, then surged by 152.57% to $14.7 million in 2022, then tumbled by 66.97% to $4.9 million in 2023, then decreased by 17.9% to $4.0 million in 2024, then soared by 261.24% to $14.4 million in 2025.
- Its last three reported values are $14.4 million in Q3 2025, $194603.0 for Q2 2025, and $3.8 million during Q1 2025.